Could a gene therapy shot boost brain health? new study begins

NCT ID NCT07216781

Recruiting now Disease control Sponsor: Minicircle Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new gene therapy that aims to increase levels of a protein called Klotho, which is linked to better brain function and overall health. The trial involves 24 healthy adult volunteers who will receive a single injection of the therapy. Researchers will monitor safety and measure changes in Klotho levels, as well as markers related to kidney and bone health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULTS

Contacts and locations

Locations

Apeiron Center
RECRUITING

Austin, Texas, 78701, United States
GARM Clinic
NOT_YET_RECRUITING

Roatán, Bay Islands, Honduras

More trials for these conditions

Other studies related to the condition(s) this trial covers.